Chris Manfuso is a sales expert that graduated Cum Laude from James Madison University. Presently, Chris Manfuso works as the National Director of sales at Nubratori in Torrance, CA. Nubratori manufactures the Endura-kit on behalf of Ventis Pharmaceuticals.
Endura-kit is an anesthetic product recently created by Ventis Pharm, a pharmaceutical company affiliated with Nubratori. The product is a combination of two effective and safe anesthetics. The resultant effect of this combination is an aqueous solution of 0.2% tetracaine, 0.4% lidocaine, and 4mcg per milliliter of epinephrine. The performance of Endura-kit meets the expectation for liposomally encapsulated bupivacaine products.
Apart from the production of Endura-kit, Ventis Pharm presently engages in research that aims at creating user-friendly, moderate cost adjuvants that augment the effects of local anesthetic applications. Ventis Pharm’s current research efforts align with the American Society of Anesthesiology’s recent publication, “Anesthesiology.” The publication centered on the low efficacy level of liposomally encapsulated bupivacaine products. Ventis Pharm aims at providing remedies in relation to the application of local anesthetics.
Chris Manfuso 